Works matching IS 09509232 AND DT 2013 AND VI 32 AND IP 20

Results: 11

Rictor regulates cell migration by suppressing RhoGDI2.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2521, doi. 10.1038/onc.2012.287

By:

Agarwal, N K;
Chen, C-H;
Cho, H;
Boulbès, D R;
Spooner, E;
Sarbassov, D D

Publication type:

Article

The orphan receptor GPR55 drives skin carcinogenesis and is upregulated in human squamous cell carcinomas.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2534, doi. 10.1038/onc.2012.278

By:

Pérez-Gómez, E;
Andradas, C;
Flores, J M;
Quintanilla, M;
Paramio, J M;
Guzmán, M;
Sánchez, C

Publication type:

Article

Autophagy restricts proliferation driven by oncogenic phosphatidylinositol 3-kinase in three-dimensional culture.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2543, doi. 10.1038/onc.2012.277

By:

Chen, N;
Eritja, N;
Lock, R;
Debnath, J

Publication type:

Article

Histone arginine methylation keeps RUNX1 target genes in an intermediate state.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2565, doi. 10.1038/onc.2012.274

By:

Herglotz, J;
Kuvardina, O N;
Kolodziej, S;
Kumar, A;
Hussong, H;
Grez, M;
Lausen, J

Publication type:

Article

Progestin suppression of miR-29 potentiates dedifferentiation of breast cancer cells via KLF4.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2555, doi. 10.1038/onc.2012.275

By:

Cittelly, D M;
Finlay-Schultz, J;
Howe, E N;
Spoelstra, N S;
Axlund, S D;
Hendricks, P;
Jacobsen, B M;
Sartorius, C A;
Richer, J K

Publication type:

Article

RREB1 repressed miR-143/145 modulates KRAS signaling through downregulation of multiple targets.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2576, doi. 10.1038/onc.2012.266

By:

Kent, O A;
Fox-Talbot, K;
Halushka, M K

Publication type:

Article

PGC-1β mediates adaptive chemoresistance associated with mitochondrial DNA mutations.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2592, doi. 10.1038/onc.2012.259

By:

Yao, Z;
Jones, A W E;
Fassone, E;
Sweeney, M G;
Lebiedzinska, M;
Suski, J M;
Wieckowski, M R;
Tajeddine, N;
Hargreaves, I P;
Yasukawa, T;
Tufo, G;
Brenner, C;
Kroemer, G;
Rahman, S;
Szabadkai, G

Publication type:

Article

Reduced in vivo lung metastasis of a breast cancer cell line after treatment with Herceptin mAb conjugated to chemotherapeutic drugs.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2527, doi. 10.1038/onc.2012.283

By:

Garcia, A Galan;
Nedev, H;
Bijian, K;
Su, J;
Alaoui-Jamali, M A;
Saragovi, H U

Publication type:

Article

Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2586, doi. 10.1038/onc.2012.263

By:

Eißmann, M;
Melzer, I M;
Fernández, S B M;
Michel, G;
Hrabě de Angelis, M;
Hoefler, G;
Finkenwirth, P;
Jauch, A;
Schoell, B;
Grez, M;
Schmidt, M;
Bartholomae, C C;
Newrzela, S;
Haetscher, N;
Rieger, M A;
Zachskorn, C;
Mittelbronn, M;
Zörnig, M

Publication type:

Article

Emerging roles for the pro-oncogenic anterior gradient-2 in cancer development.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2499, doi. 10.1038/onc.2012.346

By:

Chevet, E;
Fessart, D;
Delom, F;
Mulot, A;
Vojtesek, B;
Hrstka, R;
Murray, E;
Gray, T;
Hupp, T

Publication type:

Article

Cell-penetrating H4 tail peptides potentiate p53-mediated transactivation via inhibition of G9a and HDAC1.

Published in:

Oncogene, 2013, v. 32, n. 20, p. 2510, doi. 10.1038/onc.2012.273

By:

Heo, K;
Kim, J-S;
Kim, K;
Kim, H;
Choi, J;
Yang, K;
An, W

Publication type:

Article